EUVIMEDEUVIMED entdecken
Crossref

Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine

Jacob K. Files, Paul A. Goepfert

Topics in Antiviral Medicine · 01.04.2024 · 32 (2) · 420-430

DOI: 10.68040/2024322.420430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Topics in Antiviral Medicine, 2024-04. Verfasst von Jacob K. Files und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Files, J. K., & Goepfert, P. A. (2024). Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine. Topics in Antiviral Medicine, 32(2), 420-430. https://doi.org/10.68040/2024322.420430

Vancouver

Files JK, Goepfert PA. Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine. Topics in Antiviral Medicine. 2024;32(2):420-430. doi:10.68040/2024322.420430

BibTeX
@article{Files2024,
  author = {Files, Jacob K. and Goepfert, Paul A.},
  title = {Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine},
  journal = {Topics in Antiviral Medicine},
  year = {2024},
  volume = {32},
  number = {2},
  pages = {420--430},
  doi = {10.68040/2024322.420430}
}
Kostenlos starten →